Starbucks Corp (NASDAQ:SBUX) is surging today, up 5.3% at $105.70 at last glance, despite same-store sales falling for the fourth consecutive quarter with a 4% drop. The company's fiscal first-quarter earnings of 69 cents beat estimates of 66 cents per share, while revenue came in better than expected as well. In response, a slew of analysts lifted their price targets on SBUX, including UBS to $105 from $98. 

Today's pop has Starbucks stock trading at 52-week highs as it eyes its largest single-day percentage gain since September. Since the start of 2025, SBUX is already up 15.7%. 

Over in the options pits, 124,000 calls and 64,000 puts have been exchanged, which is 9 times the average daily options volume already.  The weekly 1/31 112-strike call is the most popular contract, with new positions being bought to open there. 

Visa Inc (NYSE:V) is partnering with social media platform X, formerly known as Twitter, to launch a digital wallet along with other products. The deal aligns with CEO Elon Musk's goal of having an application that offers a broader range of services. At last check, V was up 0.5% to trade at $335.71.

Visa stock yesterday scored a record high of $337.83, following its bounce off a long-term floor at the 60-day moving average a couple of weeks ago. The shares rose 26.3% in the last six months, and are today looking to notch their fourth win in the past five sessions.

At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), V's 50-day call/put volume ratio of 2.10 sits higher than all other annual readings. This indicates options traders have favored calls over the last 10 weeks.

Drilling down to today's options activity, 59,000 calls and 27,000 puts have already been traded, which is five times the intraday average volume. The most popular contract is the weekly 1/31 185-strike call, where positions are being opened.

Shares of Moderna Inc. (NASDAQ: MRNA) are down 3.2% in premarket trading after a bear note from Goldman Sachs. The firm lowered its rating on MRNA to "neutral" from "buy," and nearly halved its price target from $99 to $51, citing ongoing vaccine revenue challenges.

If these pre-market losses hold, Moderna stock could erase part of its 8.1% year-to-date lead and deepen its 57.1% year-over-year loss. The equity may also slip below a critical technical level -- its 20-day moving average -- which could pressure it toward its Jan. 13, nearly five-year low of $31.94.

Bearish sentiment is growing, as short interest in MRNA has surged 13.6% over the past two weeks. Currently, 43.01 million shares are sold short, making up 12.4% of the stock's total float.

It's worth noting the security has a history of exceeding volatility expectations, as evidenced by its elevated Schaeffer's Volatility Scorecard (SVS) rating of 99 out of 100. This makes now a good time to weigh in on the equity's next more with options.

Israel-based pharmaceutical giant Teva Pharmaceutical Industries Ltd (NYSE:TEVA) is preparing for its latest quarterly earnings report, due out before the open Wednesday, Jan. 29. The stock snapped its positive post-earnings streak in November with a 7.1% loss, marking its first negative earnings reaction in six quarters. This time around, analysts expect the company to post earnings of 70 cents per share, and a 7.3% decrease in revenue from a year ago, per Reuters. 

On the charts, TEVA is still above its December bull gap levels, and isn't too far removed from its Dec. 27 six-year high of $22.88. Newfound support at the $21.50 region appears to be capturing today's pullback, with the stock down 1.4% at $21.47 at last glance. Year over year, the equity is up 81.5%. 

When considering tomorrow's earnings volatility, it's worth noting that analysts are mostly bullish on Teva Pharmaceuticals stock. Of the eight brokerages in coverage, seven carry a "strong buy" rating, and one a "hold." 

Gold prices are rebounding alongside the broader market from a tech-induced selloff, as investors assess U.S. President Donald Trump's proposed tariff plans. Coeur Mining Inc (NYSE:CDE) was last seen up 2.9% to trade at $6.20, bouncing off support at the $6 level, though a break above $6.50 remains elusive. While CDE has also struggled with overhead pressure at its 80-day moving average since mid-December, it still carries a 109.8% year-over-year lead.

Analysts are optimistic, with five of six in coverage calling the stock a "buy" or better. Meanwhile, short interest rose 7.1% over the last two reporting periods, and now makes up 9.2% of the security's available float. It would take these shorts more than three days to buy back their bearish bets, at the equity's average pace of trading.

Options traders lean bullish, per the security's 50-day call/put volume ratio of 13.92 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), which sits in the 81st percentile of its annual range. 

What's more, options are reasonably priced at the moment. This is per Coeur Mining stock's Schaeffer's Volatility Index (SVI) of 63%, which sits in the 23rd percentile of its annual range.

Software stock Autodesk Inc (NASDAQ:ADSK) was last seen up 3.7% at $310, after an upgrade from Mizuho to "outperform" from "neutral," with a price-target hike to $400 from $280. The brokerage noted the company's new transaction model, as well as signs of macroeconomic recovery. 

On the charts, ADKS has been steadily climbing since bouncing off the $280 level earlier this month, which rejected the shares in March. The ascending 120-day moving average lingers below as potential support as well. Year over year, the equity is up 20.2%.

The options pits have been more bearish than usual over the last two weeks. ADSK's 10-day put/call volume ratio of 3.38 over at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) ranks higher than 94% of readings from the past year. 

Sentiment appears to be shifting after today's bull note, however, as the stock has seen six times the call volume typically seen at this point. The February 320 call is the most popular, followed by the September 370 call, with new positions opening at the latter. 

These options are reasonably priced at the moment, too. This is per Autodesk stock's Schaeffer's Volatility Index (SVI) of 27%, which sits in the 19th percentile of its annual range. 

Boeing Co (NYSE:BA) stock is on the rise after the company's recovery plan, despite steeper-than-expected losses for the fourth quarter, a revenue miss, and its biggest annual loss since 2020. The company noted incidents with its commercial and defense units, as well as last year's workers' strike, but has plans to gradually increase production and deliveries of its 737 aircraft. The aerospace giant also confirmed it is working to speed up the delivery of two Air Force One aircrafts.

BA is up 4.3% to trade at $182.74 at last glance, eyeing its biggest single-day percentage gain in over a year as it chips away at its 10.5% year-over-year deficit. The stock, which is among Schaffer's top picks for 2025, surged to its highest level since August right out of the gate, and earlier this month staged bounced off its ascending 40-day moving average.

Options traders have been more bullish than usual over the past 10 weeks. This is per BA's 50-day call/put volume ratio of 1.80 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), which ranks in the 80th percentile of its annual range, showcasing a consistent preference for calls over puts.

Drilling down to today's options activity, 59,000 calls and 27,000 puts have already been traded, which is five times the intraday average volume. The most popular contract is the weekly 1/31 185-strike call, where positions are being opened.

Shares of travel industry giants Royal Caribbean Cruises Ltd (NYSE:RCL) and JetBlue Airways Corporation (NASDAQ:JBLU) are experiencing notable price swings following their recent earnings announcements.

Royal Caribbean Cruises Stock Rises on Earnings Beat

RCL is up 6.3% at $251.88 at last glance, after the company reported a robust fourth-quarter earnings beat. Adding to investor confidence, the cruise operator issued optimistic guidance for both its first-quarter and full-year earnings, surpassing Wall Street expectations. Royal Caribbean Cruises stock has shown strong performance, boasting a remarkable 91.8% year-over-year increase and a modest 2.7% gain year-to-date.

Activity in RCL's options market has spiked alongside the stock’s upward movement. So far, 6,960 call options and 4,744 put options have exchanged hands, representing 10 times the average intraday volume. Traders are targeting the weekly 1/31 260-strike call, where new positions are being opened.

JetBlue Airways Stock Brushes Off Revenue Win

JBLU, meanwhile, is down 20.4% at $6.45 at last glance, despite exceeding revenue expectations and narrowing its fourth-quarter losses. The airline tempered investor optimism by warning of higher-than-anticipated capital expenditures, which weighed heavily on sentiment. As a result, JetBlue Airways stock has fallen into negative territory for 2025, reversing gains from its longer-term 40% year-over-year climb.

The earnings event has also spurred a surge in options activity for JBLU. Already today, 13,000 call options and 18,000 put options have traded, marking 11 times the usual volume. The most active contracts are the weekly 1/31 6.50-strike put and the 7-strike put from the same series, with significant new positions opening in both.